While the clinical trial landscape is ever evolving, the need to supply patients with safe and compliant IMP remains unaffected. Running globalized trials involving temperature sensitive products magnifies the need for sponsors to operate efficiently and mitigate risk.
One of the most high-risk areas of managing such trials is the clinical cold chain; where failure to consider potential packaging, labelling, and distribution challenges can compromise a trial’s timing, safety, and commercial viability.
Read Almac’s latest article that explores the cold chain journey, from production line to patient, to learn how you can overcome challenges within your temperature controlled supply chain. By exploring end-to-end requirements at the earliest opportunity and adjusting manufacturing strategies accordingly, safe, agile, and optimized cold chain operations can be created for your clinical trial.